Global Preclinical Imaging Market – Sketch
Market Research Future (MRFR)’s latest report on the global preclinical imaging market is a compilation of key market insights and discusses key market dynamics such as drivers, restraints, and opportunities at length. As per the analysis of MRFR, the preclinical imaging market is anticipated to expand at a CAGR of 6.3% over the forecast period of 2018-2023. The preclinical imaging market was valued at USD 2.01 Bn in 2017.
Preclinical imaging is a research modality wherein small-animal models form the keystone for research and development strategies. They are a modern approach to solving health-related problems as they enable clinically transformable methods which help in monitoring the progression of various diseases.
Preclinical imaging has assumed a significant role in the drug development and discovery process, which is a key factor driving the market growth. Being a non-invasive technique, preclinical imaging has garnered many accolades from the healthcare industry. They offer various advantages over other imaging techniques. Preclinical imaging is relatively faster, accurate, and can be applied to lengthy and repetitive procedures. Preclinical imaging has found application across various healthcare fields such as neurology, cardiology, cancer research, cardiac imaging, functional and anatomical neuroimaging, and others. Technological advancements in the field of preclinical imaging which provide enhanced diagnosis of various disease conditions and aid research on complex experiments are likely to favor the growth of the market. Other factors which have promoted the growth of the preclinical imaging is surging awareness regarding the ill-effects aligned with radiation-based imaging.
Get Exclusive Sample Copy of “Preclinical Imaging Market” Report @ https://www.marketresearchfuture.com/sample_request/7365
Regional Analysis for Global Preclinical Imaging Market
Region-wise, the preclinical imaging market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).
The global preclinical imaging market is dominated by North America on account of the presence of a robust healthcare infrastructure, technological advancements in the field of molecular imaging, and the presence of various market leaders in the region. Heightened demand for non-invasive small-animal imaging technique combined with increasing funding by the government to support preclinical imaging-based research are also promoting the growth of the market.
Europe is a major R&D hub with massive support from the governments in the form of R&D funds. Moreover, intensifying efforts by the governments to provide improved diagnostic services in the region is likely to spur the demand for preclinical imaging.
The APAC preclinical imaging market is anticipated to observe the fastest growth rate over the forecast period. Improving economic conditions and efforts to modernize the healthcare sector is speeding up the growth of the preclinical imaging market. The presence of a massive patient pool suffering from various chronic diseases is also boosting the demand for preclinical imaging.
The MEA preclinical imaging market is presumed to exhibit the least growth rate over the forecast period. The growth of the market is majorly cornered towards the Middle East, where countries such as UAE, Kuwait, and Saudi Arabia are investing heavily on the upgradation of the healthcare sector.
July 2019 – Bruker, a manufacturer of scientific instruments for molecular and materials research, announced the acquisition of PMOD Technologies LLC, a research-use-only software provider for preclinical and molecular imaging.
Key Players for Global Preclinical Imaging Market
The key market players present in the global market pre-clinical imaging are Bruker Corporation (US), PerkinElmer Inc. (US), MR Solutions (UK), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), LI-COR, Inc. (the US), Miltenyi Biotec GmbH (Germany), Aspect Imaging (Israel), and Trifoil Imaging (US).
Segments for Global Preclinical Imaging Market
The preclinical imaging market has been segmented based on modality and reagent.
By modality, the preclinical imaging market has been segmented into optical imaging system, micro-CT, nuclear imaging system, micro-MRI, micro-ultrasound, photoacoustic imaging system, and magnetic particle imaging systems.
The optical imaging system segment has been further segmented into bioluminescence/fluorescence imaging systems, standalone fluorescence imaging system, and optical + X-ray/ optical + CT systems.
The nuclear imaging systems segment has been further segmented into micro-PET system, micro-spect system, and trimodality (Spect/PET/CT) system.
By reagent, the preclinical imaging market has been segmented preclinical nuclear imaging reagents, preclinical optical imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment has been further segmented into bioluminescent imaging reagents and fluorescent imaging reagents.
The preclinical nuclear imaging reagents segment has been further segmented into preclinical PET tracers and Preclinical Spect Probes.
Regional Analysis for Global Preclinical Imaging Market
Geographically, the Americas is anticipated to dominate the global preclinical imaging market owing to a well-established player, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.
Europe is expected to hold the second largest position in the global preclinical imaging market. The market growth in this region is attributed to increasing funding to support preclinical researches.
The preclinical imaging market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.
The Middle East & Africa has the least share of the preclinical imaging market.
Browse Complete “Preclinical Imaging Market” Report @https://www.marketresearchfuture.com/reports/preclinical-imaging-market-7365
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312